These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 25008355)
21. Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy. El-Agnaf O; Overk C; Rockenstein E; Mante M; Florio J; Adame A; Vaikath N; Majbour N; Lee SJ; Kim C; Masliah E; Rissman RA Neurobiol Dis; 2017 Aug; 104():85-96. PubMed ID: 28476636 [TBL] [Abstract][Full Text] [Related]
22. Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy. Ubhi K; Inglis C; Mante M; Patrick C; Adame A; Spencer B; Rockenstein E; May V; Winkler J; Masliah E Exp Neurol; 2012 Apr; 234(2):405-16. PubMed ID: 22281106 [TBL] [Abstract][Full Text] [Related]
23. Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway. Tofaris GK; Kim HT; Hourez R; Jung JW; Kim KP; Goldberg AL Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17004-9. PubMed ID: 21953697 [TBL] [Abstract][Full Text] [Related]
24. Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. Masliah E; Rockenstein E; Mante M; Crews L; Spencer B; Adame A; Patrick C; Trejo M; Ubhi K; Rohn TT; Mueller-Steiner S; Seubert P; Barbour R; McConlogue L; Buttini M; Games D; Schenk D PLoS One; 2011 Apr; 6(4):e19338. PubMed ID: 21559417 [TBL] [Abstract][Full Text] [Related]
29. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
30. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease. Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974 [TBL] [Abstract][Full Text] [Related]
31. Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease. Kim KS; Choi YR; Park JY; Lee JH; Kim DK; Lee SJ; Paik SR; Jou I; Park SM J Biol Chem; 2012 Jul; 287(30):24862-72. PubMed ID: 22619171 [TBL] [Abstract][Full Text] [Related]
32. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease. Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514 [TBL] [Abstract][Full Text] [Related]
33. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577 [TBL] [Abstract][Full Text] [Related]
34. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology. Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088 [TBL] [Abstract][Full Text] [Related]
35. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638 [TBL] [Abstract][Full Text] [Related]
36. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain. Friedman LG; Lachenmayer ML; Wang J; He L; Poulose SM; Komatsu M; Holstein GR; Yue Z J Neurosci; 2012 May; 32(22):7585-93. PubMed ID: 22649237 [TBL] [Abstract][Full Text] [Related]
37. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses. Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558 [TBL] [Abstract][Full Text] [Related]
38. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy? De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639 [TBL] [Abstract][Full Text] [Related]
39. Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease. Park SJ; Jin U; Park SM PLoS Pathog; 2021 Oct; 17(10):e1010018. PubMed ID: 34695168 [TBL] [Abstract][Full Text] [Related]
40. Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBD. Spencer B; Michael S; Shen J; Kosberg K; Rockenstein E; Patrick C; Adame A; Masliah E Mol Ther; 2013 Jan; 21(1):31-41. PubMed ID: 22508489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]